<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SS</journal-id><journal-title-group><journal-title>Surgical Science</journal-title></journal-title-group><issn pub-type="epub">2157-9407</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ss.2021.129033</article-id><article-id pub-id-type="publisher-id">SS-112045</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Frequency of Hemorrhoidal Complaints in a Real-Life Population and Possible Concomitance between Hemorrhoidal Disease and Chronic Venous Disease: Going Further in Our Understanding of Hemorrhoidal Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sheikh</surname><given-names>Firoj Kabir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Debasish</surname><given-names>Das</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kazi</surname><given-names>Zana Alam</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahbub</surname><given-names>Murshed</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Din</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Department of Surgery, Shaheed Suhrawardy Medical College and Hospital, Dhaka, Bangladesh</addr-line></aff><aff id="aff3"><addr-line>Department of Surgery, Sylhet M.A.G. Osmani Medical College &amp;amp; Hospital, Sylhet, Bangladesh</addr-line></aff><aff id="aff4"><addr-line>Department of Surgery, Mainamoti Medical College &amp;amp; Hospital, Cumilla, Bangladesh</addr-line></aff><aff id="aff2"><addr-line>Department of Surgery, Enam Medical College &amp;amp; Hospital, Savar, Bangladesh</addr-line></aff><aff id="aff1"><addr-line>Department of Surgery, US Bangla Medical College, Narayanganj, Bangladesh</addr-line></aff><pub-date pub-type="epub"><day>17</day><month>09</month><year>2021</year></pub-date><volume>12</volume><issue>09</issue><fpage>319</fpage><lpage>331</lpage><history><date date-type="received"><day>7,</day>	<month>June</month>	<year>2021</year></date><date date-type="rev-recd"><day>15,</day>	<month>September</month>	<year>2021</year>	</date><date date-type="accepted"><day>18,</day>	<month>September</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   <b><b>Introduction:</b></b> Hemorrhoids, more commonly known as piles, are swollen veins, similar to varicose veins in the lower rectum. Hemorrhoids can develop both inside and outside the rectum, and oftentimes, the cause of hemorrhoids remains unknown. This is an extremely common ailment faced by three out of four adults in their lifetime. Hemorrhoids can cause various kinds of complications, but the most common and serious ones are perianal thrombosis and incarcerated prolapsed internal hemorrhoids with subsequent thrombosis. They are accompanied by severe pain in the perianal region, and possible bleeding. Data on the coexistence of hemorrhoids with other conditions are sparse. Some data are consistent with a common pathophysiological link between straining at stool, constipation, and obstetrical events such as pregnancy and delivery. These events are also involved in the development of Chronic Vein Disease (CVD) or Chronic Vein Insufficiency (CVI). CVI is a condition that occurs when the venous walls or valves in the leg veins stop working properly, causing difficulty in blood returning to the heart from the legs. The present study was conducted with an aim to determine the frequency of complaints in hemorrhoidal patients and to assess the possible concomitance between hemorrhoidal disease and chronic venous disease. <b></b><b><b>Methods:</b></b> This was a multicenter, cross-sectional, observational study that enrolled patients spontaneously consulting for hemorrhoids in 17 different hospitals of different regions of Bangladesh from 1<sup>st</sup> June 2018 to 31<sup>st</sup> July 2018. Patients’ demographic and lifestyle characteristics were recorded, information on hemorrhoidal grade and signs of chronic venous disease was collected. Types of prescribed treatments were also recorded by the physicians. <b></b><b><b>Results:</b></b><b> </b>A total of 499 patients were enrolled and analyzed. Reported frequencies of hemorrhoidal symptoms were: bleeding (80.8%), pain (66.3%), swelling (51.7%), prolapse (28.9%), itching (37.7%), soiling (12%), fecal incontinence (13.4%). 13.8% of the hemorrhoidal patients presented concomitant chronic venous disease. The Clinical-Etiological-Anatomical-Pathophysiological (CEAP) classification was used to classify the clinical signs and symptoms of the patients as C0—no visible or palpable signs of venous disease (6.2%), C1—telangiectasias or reticular veins (4.4%), C2—varicose veins (1.4%), C3—edema (2.6%), C4a—pigmentation or eczema (2%), C4b—lipodermatosclerosis or Atrophie Blanche (0.2%), C5 &amp; C6—venous ulcer (0.6%). Commonly prescribed treatments were dietary fiber (89.8%), veno-active drugs (74.7%), topical treatments (63.7%), painkillers (11.2%), and surgical procedures (30.3%). <b></b><b><b>Conclusion:</b></b><b> </b>The study provides small-scale data on patient profiles, risk factors, and commonly prescribed treatments in hemorrhoidal patients. The concomitance of chronic venous disease in 13.8% of the hemorrhoidal patients highlights the importance 
 
</p></abstract><kwd-group><kwd>Hemorrhoidal Complaints</kwd><kwd> Chronic Venous Disease</kwd><kwd> Frequency</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hemorrhoidal disease is considered to be one of the most common anorectal pathological conditions worldwide. Though symptomatic hemorrhoidal disease significantly hampers the quality of life, in most cases, patients are disinclined to seek medical attention. This makes it difficult to determine the exact incidence of the condition. Hemorrhoid disease is said to be the fourth leading outpatient gastrointestinal diagnosis, accounting for 3.3 million ambulatory care visits in the United States [<xref ref-type="bibr" rid="scirp.112045-ref1">1</xref>]. Although so common, only around 4% seek medical help [<xref ref-type="bibr" rid="scirp.112045-ref2">2</xref>]. Levels of spontaneous consultation for hemorrhoidal symptoms worldwide are only around 2%, increasing to around 14% when patients presenting for an unrelated condition are subject to targeted questioning [<xref ref-type="bibr" rid="scirp.112045-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref4">4</xref>]. The most common complaints related to hemorrhoids are bleeding, pain during defecation, swelling, prolapse, itching and fecal incontinence.</p><p>The exact pathophysiology of hemorrhoidal disease is still not completely understood. Several mechanisms may be involved including sliding anal cushion, hyperperfusion of hemorrhoidal plexus, vascular abnormality, tissue inflammation, and internal rectal prolapse. Factors like constipation, straining during defecation, pregnancy, obesity aggravate the above-mentioned pathologic changes. These factors are also involved in chronic venous disease development. The co-morbidity of these two disease conditions is yet to be properly evaluated. <sup> </sup></p><p>The different philosophies of hemorrhoidal disease development may lead to different approaches to the treatment of hemorrhoids [<xref ref-type="bibr" rid="scirp.112045-ref5">5</xref>]. Dietary and lifestyle modifications remain the primary choice of physicians for hemorrhoidal disease management. Other treatments include pharmacological approach, hemorrhoidectomy, and other non-excisional surgeries.</p><p>In light of these data, this study aimed to determine the frequency of complaints such as pain, bleeding, rectal swelling, itching, soiling, as well as constipation in subjects consulting for hemorrhoids and to assess the possible concomitance between hemorrhoids and chronic venous disorders.</p></sec><sec id="s2"><title>2. Methods</title><p>This was a multi-center, cross-sectional, observational study. The study was conducted by 20 Physicians involved in hemorrhoidal disease management from 17 hospitals located in different regions of Bangladesh. The study period lasted for 2 months, from 1<sup>st</sup> June 2018 to 31<sup>st</sup> July 2018. Convenient sampling technique was used for selection of the study sample. After obtaining informed consent, 499 Patients aged over 18 years and consulting spontaneously for hemorrhoidal complaints or referred by another physician for hemorrhoids were enrolled. Patients who were consulting for other emergencies except hemorrhoids were excluded from the program. Informed written consent was taken from all the participants. Ethical approval was taken from the Department of Surgery, US Bangla Medical College, Narayanganj, Bangladesh.</p><p>Demographic data and lifestyle characteristics of the subjects were collected including age, sex, body mass index, occupationally activeness, duration of standing position in a day, smoking habits, and obstetrical history. Subjects were asked to describe their anal complaints including symptoms, presence or duration of constipation, duration of evacuation, use of laxatives, consistency of stools in the last 15 days using the Bristol stool scale, [<xref ref-type="bibr" rid="scirp.112045-ref6">6</xref>] history of hemorrhoids. Patient examination, if performed, was described (digital and/or anoscopy) and the type (internal, external or mixed) and grade of hemorrhoids were noted. Internal hemorrhoids were graded from I to IV according to the classification of Goligher et al. [<xref ref-type="bibr" rid="scirp.112045-ref7">7</xref>] Patients were also questioned about the chronic venous disease of the lower extremities and chronic venous disease was graded according to the revised CEAP (Clinical manifestations, Etiologic factors, Anatomic distribution of disease, and underlying Pathophysiology) classification [<xref ref-type="bibr" rid="scirp.112045-ref8">8</xref>]. Details of any hemorrhoidal treatment prescribed including dietary fiber, topical treatment, veno-active drugs, pain killers, and surgery (including minimally-invasive procedures) were recorded. All necessary information was collected through a detailed questionnaire and test results of participants, and the collected data was compiled and analyzed using SPSS software.</p></sec><sec id="s3"><title>3. Results</title><p>The study included 499 patients with hemorrhoids who met the selection criteria. The mean age was 38.6 &#177; 11.4 years (range 15 - 83 years) and the male:female ratio was 1.6:1 [<xref ref-type="table" rid="table1">Table 1</xref>]. BMI was normal for most of the participants [<xref ref-type="table" rid="table2">Table 2</xref>]. 71.5% of the participants were occupationally active [<xref ref-type="table" rid="table3">Table 3</xref>]. Duration of standing position during the day was less than 2 hours for 46.7% of the participants [<xref ref-type="table" rid="table4">Table 4</xref>]. Most of the participants (60.5%) were nonsmokers [<xref ref-type="table" rid="table5">Table 5</xref>]. Most of the participants (87.4%) had given birth before [<xref ref-type="table" rid="table6">Table 6</xref>]. Less than 18 months of constipation was recorded for most of the participants [<xref ref-type="table" rid="table7">Table 7</xref>]. 32.1% were laxative medication users [<xref ref-type="table" rid="table8">Table 8</xref>]. 67.1% of participants had evacuation lengths of 6 to 30 minutes [<xref ref-type="table" rid="table9">Table 9</xref>]. Consistency of stools in the last 15 days (without laxatives) were type 3 in 23.8% of participants [<xref ref-type="table" rid="table1">Table 1</xref>0]. History of hemorrhoids was present in 68.1% and among them, history of hemorrhoids once was present in 43.8% [<xref ref-type="table" rid="table1">Table 1</xref>1]. 92.4% were examined. Among them, 38.9% were digitally examined [<xref ref-type="table" rid="table1">Table 1</xref>2]. Grade 2 hemorrhoids were present in the maximum (37%) number of the participants after examination [<xref ref-type="table" rid="table1">Table 1</xref>3]. The most frequently encountered complaints were bleeding (80.8%), pain (66.3%), swelling (51.7%), prolapse (28.9%), itching (37.7%), soiling (12%) and fecal incontinence (13.4%) [<xref ref-type="fig" rid="fig1">Figure 1</xref>]. Among the hemorrhoidal patients, 13.8% presented concomitant chronic venous disease. CEAP classification was used to classify the clinical signs and symptoms of the patients as C0 (6.2%), C1 (4.4%), C2 (1.4%), C3 (2.6%), C4a (2%), C4b (0.2%) and C5 - C6 (0.6%) [<xref ref-type="fig" rid="fig2">Figure 2</xref>]. Maximum patients (89.8%) were prescribed Dietary fiber. Topical treatment,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Age distribution of the study respondents</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age group (in years)</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >21 - 30</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >26.1</td></tr><tr><td align="center" valign="middle" >31 - 40</td><td align="center" valign="middle" >186</td><td align="center" valign="middle" >37.3</td></tr><tr><td align="center" valign="middle" >41 - 50</td><td align="center" valign="middle" >104</td><td align="center" valign="middle" >20.8</td></tr><tr><td align="center" valign="middle" >51 - 60</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >9.2</td></tr><tr><td align="center" valign="middle" >61 - 70</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >4.2</td></tr><tr><td align="center" valign="middle" >&gt;70</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD</td><td align="center" valign="middle"  colspan="2"  >38.6 &#177; 11.4</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Sex</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >308</td><td align="center" valign="middle" >61.7</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >191</td><td align="center" valign="middle" >38.3</td></tr><tr><td align="center" valign="middle" >Male:Female ratio</td><td align="center" valign="middle"  colspan="2"  >1.6:1</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of the study respondents by BMI</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >BMI (kg/m<sup>2</sup>)</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Underweight (&lt;18.5)</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >4.8</td></tr><tr><td align="center" valign="middle" >Normal (18.5 - 24.9)</td><td align="center" valign="middle" >259</td><td align="center" valign="middle" >51.9</td></tr><tr><td align="center" valign="middle" >Overweight (25.0 - 29.9)</td><td align="center" valign="middle" >147</td><td align="center" valign="middle" >29.5</td></tr><tr><td align="center" valign="middle" >Obese (&gt;30.0)</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >13.8</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of the study respondents by occupationally activeness</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Occupationally activeness</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >357</td><td align="center" valign="middle" >71.5</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >142</td><td align="center" valign="middle" >28.5</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of the study respondents by duration of standing position during in a day</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration (hours)</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >2 hours or less</td><td align="center" valign="middle" >233</td><td align="center" valign="middle" >46.7</td></tr><tr><td align="center" valign="middle" >Between 3 and 6 hours</td><td align="center" valign="middle" >201</td><td align="center" valign="middle" >40.3</td></tr><tr><td align="center" valign="middle" >7 hours or more</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >13.0</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of the study respondents by smoking status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Smoking status</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Never</td><td align="center" valign="middle" >302</td><td align="center" valign="middle" >60.5</td></tr><tr><td align="center" valign="middle" >Now</td><td align="center" valign="middle" >132</td><td align="center" valign="middle" >26.5</td></tr><tr><td align="center" valign="middle" >Quit</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >13.0</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of the study respondents by obstetrical history</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Obstetrical history</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Use birth control pills</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >50.8</td></tr><tr><td align="center" valign="middle" >Use estrogen replacement therapy</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >14.7</td></tr><tr><td align="center" valign="middle" >Birth given</td><td align="center" valign="middle" >167</td><td align="center" valign="middle" >87.4</td></tr><tr><td align="center" valign="middle" >Number of births</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >One Two Three Four Five</td><td align="center" valign="middle" >42 45 39 17 7</td><td align="center" valign="middle" >22.0 23.6 20.4 8.9 3.7</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Distribution of the study respondents by constipation</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Constipation</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Not constipated</td><td align="center" valign="middle" >112</td><td align="center" valign="middle" >22.4</td></tr><tr><td align="center" valign="middle" >Less than 18 months</td><td align="center" valign="middle" >229</td><td align="center" valign="middle" >45.9</td></tr><tr><td align="center" valign="middle" >More than 5 years</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >14.0</td></tr><tr><td align="center" valign="middle" >Not known</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >17.6</td></tr></tbody></table></table-wrap><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Distribution of the study respondents by regular use of laxatives</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Regular of laxatives</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >160</td><td align="center" valign="middle" >32.1</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >339</td><td align="center" valign="middle" >67.9</td></tr></tbody></table></table-wrap><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> Distribution of the study respondents based on the evacuation</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration of evacuation</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Less than 5 minutes</td><td align="center" valign="middle" >139</td><td align="center" valign="middle" >27.9</td></tr><tr><td align="center" valign="middle" >6 to 30 minutes</td><td align="center" valign="middle" >335</td><td align="center" valign="middle" >67.1</td></tr><tr><td align="center" valign="middle" >More than 30 minutes</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >5.0</td></tr></tbody></table></table-wrap><table-wrap id="table10" ><label><xref ref-type="table" rid="table1">Table 1</xref>0</label><caption><title> Distribution of the study respondents by consistency of stools in the last 15 days (without laxatives)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Consistency of stools</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Type 1</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >10.0</td></tr><tr><td align="center" valign="middle" >Type-2</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >17.8</td></tr><tr><td align="center" valign="middle" >Type 3</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >23.8</td></tr><tr><td align="center" valign="middle" >Type 4</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >20.4</td></tr><tr><td align="center" valign="middle" >Type 5</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >4.4</td></tr><tr><td align="center" valign="middle" >Type 6</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Type 7</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Missing</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >20.2</td></tr></tbody></table></table-wrap><table-wrap id="table11" ><label><xref ref-type="table" rid="table1">Table 1</xref>1</label><caption><title> Distribution of the study respondents by history of hemorrhoids</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >History of hemorrhoids</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >340</td><td align="center" valign="middle" >68.1</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >159</td><td align="center" valign="middle" >31.9</td></tr><tr><td align="center" valign="middle" >If yes, how many times in the last 2 yrs.</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Once</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" >43.8</td></tr><tr><td align="center" valign="middle" >Twice</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >35.0</td></tr><tr><td align="center" valign="middle" >Between 3 and 5 times</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >18.2</td></tr><tr><td align="center" valign="middle" >6 times or more</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >2.9</td></tr></tbody></table></table-wrap><table-wrap id="table12" ><label><xref ref-type="table" rid="table1">Table 1</xref>2</label><caption><title> Distribution of the study respondents by examination</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patients examination</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >470</td><td align="center" valign="middle" >94.2</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >5.8</td></tr><tr><td align="center" valign="middle" >If examined-</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Digital examination</td><td align="center" valign="middle" >187</td><td align="center" valign="middle" >39.8</td></tr><tr><td align="center" valign="middle" >Anoscopic examination</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >24.3</td></tr><tr><td align="center" valign="middle" >Both</td><td align="center" valign="middle" >169</td><td align="center" valign="middle" >36.0</td></tr></tbody></table></table-wrap><table-wrap id="table13" ><label><xref ref-type="table" rid="table1">Table 1</xref>3</label><caption><title> Distribution of the study respondents by after examination grade of hemorrhoids</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patients examination</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >459</td><td align="center" valign="middle" >92.0</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >8.0</td></tr><tr><td align="center" valign="middle" >If yes, the grade of hemorrhoids</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Grade I</td><td align="center" valign="middle" >122</td><td align="center" valign="middle" >26.6</td></tr><tr><td align="center" valign="middle" >Grade II</td><td align="center" valign="middle" >170</td><td align="center" valign="middle" >37.0</td></tr><tr><td align="center" valign="middle" >Grade III</td><td align="center" valign="middle" >128</td><td align="center" valign="middle" >27.9</td></tr><tr><td align="center" valign="middle" >Grade IV</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >8.5</td></tr></tbody></table></table-wrap><p>veno-active drugs, analgesics were prescribed as conventional treatments in respectively 63.7%, 74.7%, and 11.2% of the patients. 30.3% of the patients underwent surgical procedures [<xref ref-type="fig" rid="fig3">Figure 3</xref>]. MPFF was the most prescribed veno-active drug (87.1%). 12.3% and 0.7% of the patients were prescribed Diosmin and Calcium Dobesilate respectively [<xref ref-type="fig" rid="fig4">Figure 4</xref>]. 73.4% of patients continued veno-active drugs for more than 4 weeks. 17.4% and 9.2% continued for 2 - 3 weeks and less than 1 week, respectively [<xref ref-type="fig" rid="fig5">Figure 5</xref>].</p></sec><sec id="s4"><title>4. Discussion</title><p>Almost all the participants (94.2%) underwent a clinical examination, either digital and/or anoscopic. Although a digital examination cannot always confirm a diagnosis of lower grade HD, it is important to eliminate any local malignancies. Anoscopy is necessary for the diagnosis of Grade I hemorrhoids and was performed in most patients with low-grade hemorrhoids, thus confirming the high level of diagnostic evidence in this study.</p><p>Patients from the age group of 31 - 40 years were most in numbers to consult for hemorrhoidal problems. Male predominance was found among the patients (61.7% vs. 38.3%). This may reflect the cultural habits of people living in Bangladesh making women with HD reluctant to come forward.</p><p>87.4% of the female patients had had at least one full-term pregnancy, and pregnancy is recognized as a risk factor for all grades of hemorrhoids. Hemorrhoids are common during pregnancy, particularly the last trimester, [<xref ref-type="bibr" rid="scirp.112045-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref10">10</xref>] and although they generally resolve after delivery these women are at greater risk of hemorrhoids later in life. 29.5% of the patients were in the overweight category. and 13.8% were in the obese category. Some previous studies have hypothesized that obesity may be a risk factor for HD because of increased intraabdominal pressure and increased stress on rectal muscles [<xref ref-type="bibr" rid="scirp.112045-ref11">11</xref>].</p><p>Several studies in the past, including those that have used colonoscopy to confirm hemorrhoids, have shown an increased risk in patients with chronic constipation [<xref ref-type="bibr" rid="scirp.112045-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref14">14</xref>]. Whether causal or a contributory factor in the presence of a primary cause, prolonged straining increases intra-abdominal pressure and raises venous pressure in the hemorrhoidal tissue. In this study, more than half of the subjects (59.9%) were suffering from constipation according to the Bristol stool scale and 67.1% reported a straining duration of 6 - 30 minutes.</p><p>Hemorrhoid recurrence rates have been reported to range from 4% - 30% after treatment [<xref ref-type="bibr" rid="scirp.112045-ref15">15</xref>]. In this study, 68.1% of patients had had hemorrhoidal attacks previously.</p><p>Grade II hemorrhoids were found to be the most common (37%) hemorrhoidal grade among the patients in this study followed by grade III (27.9) and grade I (26.6%) hemorrhoids. This may be because patients are often ignorant of painless bleeding or are reluctant to consult with physicians unless the symptoms are severely hampering their day-to-day lives. Bleeding (80.8%) followed by pain (66.3%) and swelling (51.7%) were the most common complaints presented.</p><p>Hemorrhoidal disease and chronic venous disease may have a common cause in the form of loss of vascular integrity, [<xref ref-type="bibr" rid="scirp.112045-ref16">16</xref>] though there are few published papers on the coexistence of these two disorders [<xref ref-type="bibr" rid="scirp.112045-ref17">17</xref>]. An early review of epidemiologic evidence for a link between HD and CVD hypothesized that chronic constipation associated with a low fiber diet was involved in both these diseases by increasing intra-abdominal pressure [<xref ref-type="bibr" rid="scirp.112045-ref17">17</xref>]. It was suggested that this pressure would easily be transmitted to the hemorrhoidal plexus, which has no valves. The valves of the lower limb veins would offer initial protection, but would eventually become incompetent and expose the veins to elevated pressure [<xref ref-type="bibr" rid="scirp.112045-ref17">17</xref>]. This hypothesis is supported by data from a Hungarian epidemiologic study of pregnant women, which found that around half with a diagnosis of HD also had constipation. Varicose veins were also more common in pregnant women with hemorrhoids compared with those without [<xref ref-type="bibr" rid="scirp.112045-ref18">18</xref>]. 13.8% of this study subjects also presented with signs and/or symptoms of CVD, the majority having a CEAP classification of C0s to C1. The finding should prompt physicians treating patients with a hemorrhoid diagnosis to also ask about CVD and vice versa.</p><p>Non-surgical approaches are preferred for lower-grade hemorrhoids because of the physiologic importance of the hemorrhoid cushions and the potential self-limiting nature of many hemorrhoidal symptoms [<xref ref-type="bibr" rid="scirp.112045-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref20">20</xref>]. When conservative therapy fails, clinical practice guidelines recommend office-based procedures such as banding, sclerotherapy, and infrared coagulation for Grade I to III hemorrhoids [<xref ref-type="bibr" rid="scirp.112045-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref21">21</xref>]. Surgical options such as hemorrhoidectomy, stapled hemorrhoidopexy, or hemorrhoidal artery ligation may be the initial step in patients with Grade III or IV hemorrhoids or in those who are refractory to or cannot tolerate office procedures [<xref ref-type="bibr" rid="scirp.112045-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref21">21</xref>]. However, conservative therapy can still play a role, creating favorable conditions for a smooth post-operative recovery [<xref ref-type="bibr" rid="scirp.112045-ref22">22</xref>]. Adherence to these guideline recommendations is important to avoid repetitive and prolonged treatment and severe complications in Grade IV disease. The majority of the patients in this study received treatment with a veno-active drug, predominantly MPFF. MPFF is an effective treatment for acute hemorrhoidal attacks, and it has been shown to serve as an effective adjuvant to surgery or other procedures in the management of hemorrhoidal diseases [<xref ref-type="bibr" rid="scirp.112045-ref23">23</xref>]. MPFF is able to address the underlying causes of both symptomatic hemorrhoids and CVD via their beneficial effects on venous tone, inflammatory processes, and microcirculatory permeability [<xref ref-type="bibr" rid="scirp.112045-ref24">24</xref>]. Early use of such agents may play a role in preventing or slowing the development and recurrence of both hemorrhoidal and CVD signs and symptoms [<xref ref-type="bibr" rid="scirp.112045-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.112045-ref26">26</xref>].</p>Limitations of the Study<p>This study was conducted in multiple centers, and under different physicians, but the communication between the physicians was not strong. The study sample was also small compared to original goal. The sensitivity of the study topic also posed a limitation on how much data was able to be collected.</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study provided small-scale data on the profiles of patients presenting with HD in clinical practice. Factors like older age, obesity, constipation, increased evacuation time, male gender, and pregnancy were identified as having a statistically significant association with hemorrhoidal disease. Further studies are needed to confirm the co-relation between HD and CVD. If confirmed, a common targeted therapy needs to be given for both diseases. Moreover, since patients are less likely to spontaneously come forward with hemorrhoidal symptoms, physicians should consider the above-mentioned risk factors and be proactive in diagnosing hemorrhoids if suspected. As hemorrhoidal symptoms affect patients in all grades, a conservative treatment therefore should be the cornerstone of care.</p></sec><sec id="s6"><title>Approval</title><p>Got approval from the respective department.</p></sec><sec id="s7"><title>Authors Contributions</title><p>SF Kabir designed and developed the study. DDas and KZ Alam collected data and prepared the manuscript, M Murshed and D Mohammad data analyzed and revised the draft and provided technical guidance. SF Kabir and DDas re-reviewed the manuscript and finalized the manuscript.</p></sec><sec id="s8"><title>Acknowledgements</title><p>We thank Dr. Md Ariful Islam, Bagerhat Sadar Hospital, Dr. Shiladitya Shil, Dinajpur Sadar Hospital, Dr. Shaikh Adnan Rakib, Bangladesh Medical College &amp; Hospital, Dr. Gouranga Kumar Bose, Sheikh Hasina Medical College &amp; Hospital, Dr. Shakera Ahmed, Chattogram Medical College &amp; Hospital, Dr. Sonia Akter, Enam Medical College &amp; Hospital, Dr. Mohammad Arif Hossain, Cox’s Bazar Medical College &amp; Hospital, Dr. Gazi Muhammad Salahuddin, Faridpur Medical College &amp; Hospital, Dr. Sreekanta Chandra Banik, Chattogram Medical College &amp; Hospital, Dr. Mohammad Yunus Haroon Chowdhury, Chattogram Medical College &amp; Hospital, Dr. Md. Aziz Ullah, Cumilla Medical College &amp; Hospital, Dr. Mahmud Sultan, BIRDEM General Hospital, Dr. Md. Sadekul Alom Piash, Moulvibazar 250 Bedded Hospital, Dr. Sayera Banu Sheuly, Chattogram Medical College &amp; Hospital, Dr. S. K. Forhad, Victoria General Hospital for their valuable contribution to the data collection for this research.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s10"><title>Cite this paper</title><p>Kabir, S.F., Das, D., Alam, K.Z., Murshed, M. and Mohammad, D. (2021) Frequency of Hemorrhoidal Complaints in a Real-Life Population and Possible Concomitance between Hemorrhoidal Disease and Chronic Venous Disease: Going Further in Our Understanding of Hemorrhoidal Disease. Surgical Science, 12, 319-331. https://doi.org/10.4236/ss.2021.129033</p></sec></body><back><ref-list><title>References</title><ref id="scirp.112045-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Everhart, J.E. and Ruhl, CE. (2009) Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal Diseases. Gastroenterology, 136, 376-386. https://doi.org/10.1053/j.gastro.2008.12.015</mixed-citation></ref><ref id="scirp.112045-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Liebach, J.R. and Cerda, J.J. (1991) Hemorrhoids: Modern Treatment Methods. Journal of Hospital Medicine, 53-68.</mixed-citation></ref><ref id="scirp.112045-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Abramowitz, L., Benabderrahmane, M., Pospait, D., Philip, D. and Laouénan, C. (2014) The Prevalence of Proctological Symptoms amongst Patients Who See General Practitioners in France. European Journal of General Practice, 20, 301-306. https://doi.org/10.3109/13814788.2014.899578</mixed-citation></ref><ref id="scirp.112045-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Tournu, G., Abramowitz, L., Couffignal, C., Juguet, F., Sénéjoux, A., Berger, S., et al. (2017) GREP Study Group; MG-PREVAPROCT Study Group. Prevalence of Anal Symptoms in General Practice: A Prospective Study. BMC Family Practice, 18, Article No. 78. https://doi.org/10.1186/s12875-017-0649-6</mixed-citation></ref><ref id="scirp.112045-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Lohsiriwat, V. (2012) Hemorrhoids: From Basic Pathophysiology to Clinical Management. World Journal of Gastroenterology, 18, 2009-2017. https://doi.org/10.3748/wjg.v18.i17.2009</mixed-citation></ref><ref id="scirp.112045-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Heaton, K.W., Radvan, J., Cripps, H., Mountford, R.A., Braddon, F.E. and Hughes, A.O. (1992) Defecation Frequency and Timing, and Stool Form in the General Population: A Prospective Study. Gut, 33, 818-824. https://doi.org/10.1136/gut.33.6.818</mixed-citation></ref><ref id="scirp.112045-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Goligher, J.C. (1980) Haemorrhoids or Piles. Surgery of the Anus, Rectum and Colon, 4th Edition, Baillere Tindall, London, 93-135.</mixed-citation></ref><ref id="scirp.112045-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Eklof, B., Rutherford, R.B., Bergan, J.J., Carpentier, P.H., Gloviczki, P., Kistner, R.L., et al. (2004) American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification—Revision of the CEAP Classification for Chronic Venous Disorders: Consensus Statement. Journal of Vascular Surgery, 40, 1248-1252. https://doi.org/10.1016/j.jvs.2004.09.027</mixed-citation></ref><ref id="scirp.112045-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Avsar, A.F. and Keskin, H.L. (2010) Haemorrhoids during Pregnancy. Journal of Obstetrics and Gynaecology, 30, 231-237. https://doi.org/10.3109/01443610903439242</mixed-citation></ref><ref id="scirp.112045-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Hollingshead, J.R. and Phillips, R.K. (2016) Haemorrhoids: Modern Diagnosis and Treatment. Postgraduate Medical Journal, 92, 4-8. https://doi.org/10.1136/postgradmedj-2015-133328</mixed-citation></ref><ref id="scirp.112045-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Chang, S.S., Sung, F.C., Lin, C.L. and Hu, W.S. (2017) Association between Hemorrhoid and Risk of Coronary Heart Disease: A Nationwide Population-Based Cohort Study. Medicine (Baltimore), 96, Article ID: e7662. https://doi.org/10.1097/MD.0000000000007662</mixed-citation></ref><ref id="scirp.112045-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Singh, G., Lingala, V., Wang, H., Vadhavkar, S., Kahler, K.H., Mithal, A., et al. (2007) Use of Health Care Resources and Cost of Care for Adults with Constipation. Clinical Gastroenterology and Hepatology, 5, 1053-1058. https://doi.org/10.1016/j.cgh.2007.04.019</mixed-citation></ref><ref id="scirp.112045-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Riss, S., Weiser, F.A., Schwameis, K., Mittlb&amp;#246ck, M. and Stift, A. (2011) Haemorrhoids, Constipation and Faecal Incontinence: Is There Any Relationship? Colorectal Disease, 13, e227-e233. https://doi.org/10.1111/j.1463-1318.2011.02632.x</mixed-citation></ref><ref id="scirp.112045-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Peery, A.F., Sandler, R.S., Galanko, J.A., Bresalier, R.S., Figueiredo, J.C., Ahnen, D.J., et al. (2015) Risk Factors for Hemorrhoids on Screening Colonoscopy. PLoS ONE, 10, e0139100. https://doi.org/10.1371/journal.pone.0139100</mixed-citation></ref><ref id="scirp.112045-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sanchez, C. and Chinn, B.T. (2011) Hemorrhoids. Clinics in Colon and Rectal Surgery, 24, 5-13. https://doi.org/10.1055/s-0031-1272818</mixed-citation></ref><ref id="scirp.112045-ref16"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MacKay</surname><given-names> D. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>Hemorrhoids and Varicose Veins: A Review of Treatment Options</article-title><source> Alternative Medicine Review</source><volume> 6</volume>,<fpage> 126</fpage>-<lpage>140</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.112045-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Burkitt, D.P. (1972) Varicose Veins, Deep Vein Thrombosis, and Haemorrhoids: Epidemiology and Suggested Aetiology. The BMJ, 2, 556-561. https://doi.org/10.1136/bmj.2.5813.556</mixed-citation></ref><ref id="scirp.112045-ref18"><label>18</label><mixed-citation publication-type="book" xlink:type="simple">Acs, N., B&amp;#225nhidy, F. and Czeizel, A.E. (Eds.) Congenital Abnormalities and Preterm Birth Related to Maternal Illnesses during Pregnancy, Chapter 10.12. Springer, Berlin, 234-237.</mixed-citation></ref><ref id="scirp.112045-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Higuero, T., Abramowitz, L., Castinel, A., Fathallah, N., Hemery, P., Laclotte Duhoux, C., et al. (2016) Guidelines for the Treatment of Hemorrhoids (Short Report). Journal of Visceral Surgery, 153, Article ID: 213218. https://doi.org/10.1016/j.jviscsurg.2016.03.004</mixed-citation></ref><ref id="scirp.112045-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Davis, B.R., Lee-Kong, S.A., Migaly, J., Feingold, D.L. and Steele, S.R. (2018) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Diseases of the Colon &amp; Rectum, 61, 284-292. https://doi.org/10.1097/DCR.0000000000001030</mixed-citation></ref><ref id="scirp.112045-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Wald, A., Bharucha, A.E., Cosman, B.C. and Whitehead, W.E. (2014) ACG Clinical Guideline: Management of Benign Anorectal Disorders. The American Journal of Gastroenterology, 109, 1141-1157. https://doi.org/10.1038/ajg.2014.190</mixed-citation></ref><ref id="scirp.112045-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Zagriadski&amp;#301, E.A. (2018) Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Atudy. Advances in Therapy, 35, 1979-1993. https://doi.org/10.1007/s12325-018-0794-x</mixed-citation></ref><ref id="scirp.112045-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Agarwal, N., Singh, K., Sheikh, P., Mittal, K., Mathai, V. and Kumar, A. (2017) Executive Summary—The Association of Colon &amp; Rectal Surgeons of India (ACRSI) Practice Guidelines for the Management of Haemorrhoids—2016. Indian Journal of Surgery, 79, 58-61. https://doi.org/10.1007/s12262-016-1578-7</mixed-citation></ref><ref id="scirp.112045-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Katsenis, K. (2005) Micronized Purified Flavonoid Fraction (MPFF): A Review of Its Pharmacological Effects, Therapeutic Efficacy and Benefits in the Management of Chronic Venous Insufficiency. Current Vascular Pharmacology, 3, 1-9. https://doi.org/10.2174/1570161052773870</mixed-citation></ref><ref id="scirp.112045-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Misra, M.C. and Parshad, R. (2000) Randomized Clinical Trial of Micronized Flavonoids in the Early Control of Bleeding from Acute Internal Haemorrhoids. British Journal of Surgery, 87, 868-872. https://doi.org/10.1046/j.1365-2168.2000.01448.x</mixed-citation></ref><ref id="scirp.112045-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Nicolaides, A.N., Allegra, C., Bergan, J., Bradbury, A., Cairols, M., Carpentier, P., et al. (2008) Management of Chronic Venous Disorders of the Lower Limbs: Guidelines according to Scientific Evidence. International Angiology, 27, 1-59. https://doi.org/10.1177/000331970005100101</mixed-citation></ref></ref-list></back></article>